BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6420056)

  • 1. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
    Shenouda G; Thomson DM
    Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T8 and T3 surface glycoproteins in human T-cell mediation of leukocyte adherence inhibition to extracts of autologous cancer.
    Labateya N; Thomson DM
    J Natl Cancer Inst; 1985 Dec; 75(6):987-94. PubMed ID: 2999497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
    Thomson DM; Halliday WJ; Phelan K
    J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible abnormal nonadherence to glass and responsiveness to chemoattractants of leukocytes from patients with advanced cancer.
    Thomson DM
    J Natl Cancer Inst; 1984 Sep; 73(3):607-16. PubMed ID: 6088879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
    Shenouda G; Thomson DM
    Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence in advanced cancer of an activated leukocyte state to explain the reversible defect in transmembrane signaling and leukocyte adherence inhibition to extracts of cancer.
    Shenouda G; Thomson DM
    Clin Immunol Immunopathol; 1984 Aug; 32(2):212-23. PubMed ID: 6375921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4.
    Ondrey F; Harris JE; Anderson KM
    Cancer Res; 1989 Mar; 49(5):1138-42. PubMed ID: 2492901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
    Kotlar HK; Sanner T
    J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
    Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
    Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular mechanism of leukocyte adherence inhibition.
    Koppi TA; Maluish AE; Halliday WJ
    J Immunol; 1979 Nov; 123(5):2255-60. PubMed ID: 314958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D; Fritze J; Kaufmann M; Drings P
    Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.